Profile | GDS4284 / 224577_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1124.84 | 76 |
GSM687648 | Patient 402 control | 1163.59 | 76 |
GSM687653 | Patient 403 control | 1018.75 | 75 |
GSM687658 | Patient 404 control | 1021.92 | 74 |
GSM687663 | Patient 411 control | 1307.66 | 78 |
GSM687668 | Patient 422 control | 1039.95 | 74 |
GSM687673 | Patient 424 control | 1116.98 | 75 |
GSM687678 | Patient 425 control | 1149.95 | 75 |
GSM687683 | Patient 427 control | 1028.19 | 74 |
GSM687688 | Patient 428 control | 1649.12 | 81 |
GSM687695 | Patient 441 control | 1990.29 | 85 |
GSM687699 | Patient 443 control | 1722.57 | 82 |
GSM687704 | Patient 444 control | 834.812 | 71 |
GSM687707 | Patient 448 control | 676.976 | 68 |
GSM687712 | Patient 449 control | 1521.14 | 80 |
GSM687719 | Patient 450 control | 1128.98 | 76 |
GSM687724 | Patient 451 control | 653.101 | 68 |
GSM687728 | Patient 452 control | 1486.68 | 80 |
GSM687646 | Patient 401 treated 24h | 1053.34 | 74 |
GSM687649 | Patient 402 treated 24h | 1227.65 | 77 |
GSM687665 | Patient 411 treated 24h | 1260.02 | 77 |
GSM687651 | Patient 402 treated 4 weeks | 1406.58 | 79 |
GSM687667 | Patient 411 treated 4 weeks | 1123.88 | 75 |
GSM687670 | Patient 422 treated 24h | 893.886 | 72 |
GSM687671 | Patient 422 treated 4 weeks | 1295.03 | 77 |
GSM687654 | Patient 403 treated 24h | 982.103 | 74 |
GSM687675 | Patient 424 treated 24h | 1044.61 | 74 |
GSM687685 | Patient 427 treated 24h | 1065.15 | 75 |
GSM687656 | Patient 403 treated 4 weeks | 846.678 | 72 |
GSM687677 | Patient 424 treated 4 weeks | 1161.32 | 76 |
GSM687687 | Patient 427 treated 4 weeks | 819.975 | 71 |
GSM687692 | Patient 428 treated 4h | 843.922 | 71 |
GSM687716 | Patient 449 treated 4h | 1303.28 | 78 |
GSM687722 | Patient 450 treated 4h | 806.775 | 70 |
GSM687680 | Patient 425 treated 24h | 1006.27 | 74 |
GSM687690 | Patient 428 treated 24h | 797.736 | 71 |
GSM687700 | Patient 443 treated 24h | 960.769 | 73 |
GSM687705 | Patient 444 treated 24h | 770.508 | 70 |
GSM687714 | Patient 449 treated 24h | 1301.5 | 78 |
GSM687721 | Patient 450 treated 24h | 709.468 | 68 |
GSM687682 | Patient 425 treated 4 weeks | 657.029 | 68 |
GSM687694 | Patient 428 treated 4 weeks | 1280.67 | 77 |
GSM687702 | Patient 443 treated 4 weeks | 1075.55 | 75 |
GSM687718 | Patient 449 treated 4 weeks | 1394.23 | 79 |
GSM687723 | Patient 450 treated 4 weeks | 1040.85 | 75 |
GSM687661 | Patient 404 treated 4h | 1125.24 | 76 |
GSM687710 | Patient 448 treated 4h | 562.708 | 66 |
GSM687726 | Patient 451 treated 4h | 646.067 | 67 |
GSM687730 | Patient 452 treated 4h | 446.845 | 52 |
GSM687660 | Patient 404 treated 24h | 916.777 | 75 |
GSM687697 | Patient 441 treated 24h | 2022.05 | 85 |
GSM687709 | Patient 448 treated 24h | 620.801 | 67 |
GSM687725 | Patient 451 treated 24h | 419.908 | 60 |
GSM687729 | Patient 452 treated 24h | 1051.83 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 899.622 | 72 |
GSM687731 | Patient 452 treated 4 weeks | 1274.54 | 77 |